METAP2 and Familial prostate cancer: METAP2-PIK3C2G in tumor T17 resulted in the seven-fold upregulation of in-frame PIK3C2G, while FARS2-BMP6 in tumor T9 may also be relevant since BMP6 is linked to invasion of prostate cancer cells [30].